ProfileGDS4718 / 228815_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 43% 45% 38% 48% 41% 37% 42% 51% 43% 46% 49% 37% 41% 31% 40% 47% 44% 38% 34% 40% 54% 37% 48% 42% 37% 36% 39% 32% 41% 35% 34% 34% 41% 44% 29% 42% 38% 43% 45% 39% 43% 38% 30% 31% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.1496743
GSM549102patient 115, normal, homogenized [OPG study]5.24745
GSM549104patient 119, normal, homogenized [OPG study]4.9008638
GSM549108patient 138, normal, homogenized [OPG study]5.437648
GSM549119patient 077, normal, homogenized [OPG study]5.0276141
GSM549133patient 032, cancer, homogenized [OPG study]4.7877537
GSM549139patient 042, cancer, homogenized [OPG study]5.0747442
GSM549099patient 107, normal, homogenized [OPG study]5.5935851
GSM549109patient 139, normal, homogenized [OPG study]5.1798343
GSM549110patient 046, normal, homogenized [OPG study]5.3135346
GSM549114patient 063, normal, homogenized [OPG study]5.4303249
GSM549122patient 082, normal, homogenized [OPG study]4.8795537
GSM549134patient 033, cancer, homogenized [OPG study]5.0161541
GSM549136patient 036, cancer, homogenized [OPG study]4.5386131
GSM549140patient 044, cancer, homogenized [OPG study]4.9416740
GSM549111patient 047, normal, homogenized [OPG study]5.3122947
GSM549113patient 057, normal, homogenized [OPG study]5.1283444
GSM549132patient 031, cancer, homogenized [OPG study]4.8850638
GSM549137patient 038, cancer, homogenized [OPG study]4.6749334
GSM549142patient 047, cancer, homogenized [OPG study]5.103440
GSM549100patient 110, normal, homogenized [OPG study]5.7312854
GSM549107patient 135, normal, homogenized [OPG study]4.8120737
GSM549115patient 068, normal, homogenized [OPG study]5.3693948
GSM549116patient 072, normal, homogenized [OPG study]5.0398542
GSM549120patient 078, normal, homogenized [OPG study]4.8252437
GSM549131patient 030, cancer, homogenized [OPG study]4.7401236
GSM549118patient 074, normal, homogenized [OPG study]4.9341639
GSM549129patient 027, cancer, homogenized [OPG study]4.6350432
GSM549123patient 088, normal, homogenized [OPG study]5.0462641
GSM549124patient 006, cancer, homogenized [OPG study]4.7939835
GSM549126patient 015, cancer, homogenized [OPG study]4.6968134
GSM549128patient 025, cancer, homogenized [OPG study]4.6840534
GSM549103patient 117, normal, homogenized [OPG study]5.0983441
GSM549117patient 073, normal, homogenized [OPG study]5.1648644
GSM549138patient 041, cancer, homogenized [OPG study]4.4913429
GSM549141patient 045, cancer, homogenized [OPG study]5.0104842
GSM549130patient 028, cancer, homogenized [OPG study]4.9145438
GSM549101patient 111, normal, homogenized [OPG study]5.1887243
GSM549105patient 128, normal, homogenized [OPG study]5.2898445
GSM549106patient 134, normal, homogenized [OPG study]4.8801839
GSM549112patient 048, normal, homogenized [OPG study]5.1322643
GSM549125patient 011, cancer, homogenized [OPG study]4.9201238
GSM549127patient 024, cancer, homogenized [OPG study]4.5326730
GSM549135patient 035, cancer, homogenized [OPG study]4.5464931